The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals
Abstract
Objective Recent studies reported an association between non-alcoholic fatty liver disease (NAFLD) and increased risk of new-onset heart failure (HF). However, the magnitude of the risk and whether this risk changes with severity of liver disease remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between NAFLD and risk of new-onset HF. Design We systematically searched Scopus, Web of Science and PubMed from database inception to March 2022 to identify eligible observational studies, in which NAFLD was diagnosed by serum biomarkers/scores, International Classification of Diseases (ICD) codes, imaging techniques or liver histology. The primary outcome was new-onset HF, as assessed mainly by ICD codes. Data from selected studies were extracted, and meta-analysis was performed using random-effects models to obtain summary hazard ratios (HRs) with 95% CIs. Results We identified 11 longitudinal cohort studies with aggregate data on 11 242 231 middle-aged individuals from different countries and 97 716 cases of incident HF over a median of 10 years. NAFLD was associated with a moderately higher risk of new-onset HF (pooled random-effects hazard ratio 1.50, 95% CI 1.34 to 1.67, p<0.0001; I 2 =94.8%). This risk was independent of age, sex, ethnicity, adiposity measures, diabetes, hypertension and other common cardiovascular risk factors. Sensitivity analyses did not change these results. The funnel plot did not show any significant publication bias. Conclusion NAFLD is associated with a 1.5-fold higher long-term risk of new-onset HF, regardless of the presence of diabetes, hypertension and other common cardiovascular risk factors. However, the observational design of the studies does not allow for proving causality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“heart failure (OR 1.5), 29”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [29]
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Self-citationEstes, C., Razavi, H. A., Loomba, R. S., Younossi, Z. M., & Sanyal, A. J. (2017) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,496
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,251
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 879
Self-citation2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Mantovani, A., Csermely, A., Petracca, G., Beatrice, G., Corey, K. E., Simon, T. G., Byrne, C. D., & Targher, G. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00308-3 · Cited by 674
Self-citationTargher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
Self-citationSGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Brown, E., Heerspink, H. J. L., Cuthbertson, D. J., & Wilding, J. P. H. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00536-5 · Cited by 581
Mantovani, A., Petracca, G., Beatrice, G., Tilg, H., Byrne, C. D., & Targher, G. (2021) · Gut · doi:10.1136/gutjnl-2020-322572 · Cited by 481
Self-citationLee, H., Lee, Y., Kim, S. U., & Kim, H. C. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.022 · Cited by 463
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut · doi:10.1136/gutjnl-2020-323082 · Cited by 402
Self-citationMantovani, A., Petracca, G., Beatrice, G., Csermely, A., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut · doi:10.1136/gutjnl-2021-324191 · Cited by 363
Self-citationSimon, T. G., Roelstraete, B., Hagström, H., Sundström, J., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2021-325724 · Cited by 335
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Anstee, Q. M., Mantovani, A., Tilg, H., & Targher, G. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0010-0 · Cited by 310
Self-citationMantovani, A., Byrne, C. D., & Targher, G. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00261-2 · Cited by 230
Self-citationAlon, L., Corica, B., Raparelli, V., Cangemi, R., Basili, S., Proietti, M., & Romiti, G. F. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab212 · Cited by 155
Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure
Shah, R. V., Anderson, A. M., Ding, J., Budoff, M. J., Rider, O. J., Petersen, S. E., Jensen, M. K., Koch, M., Allison, M., Kawel‐Boehm, N., et al. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.10.024 · Cited by 153
VanWagner, L. B., Wilcox, J. E., Ning, H., Lewis, C. E., Carr, J. J., Rinella, M. E., Shah, S. J., Lima, J. A. C., & Lloyd‐Jones, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014279 · Cited by 136
Mantovani, A., Dauriz, M., Sandri, D., Bonapace, S., Zoppini, G., Tilg, H., Byrne, C. D., & Targher, G. (2019) · Liver International · doi:10.1111/liv.14044 · Cited by 132
Self-citationDauriz, M., Mantovani, A., Bonapace, S., Verlato, G., Zoppini, G., Bonora, E., & Targher, G. (2017) · Diabetes Care · doi:10.2337/dc17-0697 · Cited by 123
Self-citationLiver Fibrosis Score Predicts Mortality in Heart Failure Patients with Preserved Ejection Fraction
Yoshihisa, A., Sato, Y., Yokokawa, T., Sato, T., Suzuki, S., Oikawa, M., Kobayashi, A., Yamaki, T., Kunii, H., Nakazato, K., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12222 · Cited by 121
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Mantovani, A., Byrne, C. D., Benfari, G., Bonapace, S., Simon, T. G., & Targher, G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.007 · Cited by 115
Self-citationNonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
Fudim, M., Zhong, L., Patel, K. V., Khera, R., Abdelmalek, M. F., Diehl, A. M., McGarrah, R. W., Molinger, J., Moylan, C. A., Rao, V. N., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021654 · Cited by 104
Barbosa, J. V., Milligan, S. C., Frick, A., Broestl, J., Younossi, Z. M., Afdhal, N. H., & Lai, M. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001606 · Cited by 101
Serum γ-Glutamyl Transferase and Risk of Heart Failure in the Community
Dhingra, R., Gona, P. N., Wang, T. J., Fox, C. S., D’Agostino, R. B., & Vasan, R. S. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207340 · Cited by 99
Vita, T. S., Murphy, D. J., Osborne, M. T., Bajaj, N. S., Keraliya, A. R., Jacob, S., Martinez, A. J. D., Nodoushani, A. Y., Bravo, P. E., Hainer, J. M., et al. (2019) · Radiology · doi:10.1148/radiol.2019181793 · Cited by 73
The association of hepatic steatosis and fibrosis with heart failure and mortality
Park, J., Kim, G., Kim, H., Lee, J., Lee, Y., Jin, S., Hur, K. Y., & Kim, J. H. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01374-8 · Cited by 73
γ-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men
Wannamethee, S. G., Whincup, P. H., Shaper, A. G., LENNON, L. T., & Sattar, N. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240457 · Cited by 63
Ichikawa, K., Miyoshi, T., Osawa, K., Miki, T., Toda, H., Ejiri, K., Yoshida, M., Nanba, Y., Yoshida, M., Nakamura, K., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01192-4 · Cited by 60
Peters, A. E., Pandey, A., Ayers, C. R., Wegermann, K., McGarrah, R. W., Grodin, J. L., Abdelmalek, M. F., Bekfani, T., Blumer, V. L., Diehl, A. M., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13250 · Cited by 59
Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank
Zou, B., Yeo, Y. H., Cheung, R. C., Ingelsson, E., & Nguyen, M. H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06954-y · Cited by 54
Allen, A. M., Therneau, T. M., Mara, K. C., Larson, J. J., Watt, K. D. S., Hayes, S. N., & Kamath, P. S. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000401 · Cited by 52
Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland
Wang, Y., Tuomilehto, J. O., Jousilahti, P., Salomaa, V. V., Li, B., Antikaínen, R., Mähönen, M., Katzmarzyk, P. T., & Hu, G. (2012) · Heart · doi:10.1136/heartjnl-2012-302972 · Cited by 48
Roh, J., Park, J., Lee, H., Yoon, Y., Kim, M., Kim, Y., Park, G., Lee, J., & Seong, I. W. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01444-x · Cited by 31
Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure
Salah, H. M., Pandey, A., Spall, H. G. C. V., Michos, E. D., McGarrah, R. W., & Fudim, M. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.02.012 · Cited by 26
Dunn, M. A., Behari, J., Rogal, S. S., O’Connell, M. R., Furlan, A., Aghayev, A., Gümüş, S., Saul, M. I., & Bae, K. T. (2013) · Liver International · doi:10.1111/liv.12285 · Cited by 25
Lee, C.-O., Li, H., Tsoi, M. F., Cheung, C., & Cheung, B. M. Y. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1943514 · Cited by 23
Cited by
Sorted by citations
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 1,082
Self-citation(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hagström, H., Shang, Y., Hegmar, H., & Nasr, P. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00193-6 · Cited by 310
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 288
Metadata
- Authors
- Mantovani, A., Petracca, G., Csermely, A., Beatrice, G., Bonapace, S., Rossi, A., Tilg, H., Byrne, C. D., & Targher, G.
- Affiliations
- University of Verona (IT)
- Ospedale Sacro Cuore Don Calabria (IT)
- Innsbruck Medical University (AT)
- University of Southampton (GB)
- Corresponding author
- Targher, Giovanni
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2022-07-25
- Volume
- 72
- Issue
- 2
- Pages
- 372-380
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W4287832822
- Cited by
- 128
- References
- 42
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 37 · 2023: 26 · 2022: 3
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- non-alcoholic fatty liver disease, heart failure, new-onset heart failure, cardiovascular risk, liver disease severity, diabetes mellitus, hypertension, cardiovascular risk factors, middle-aged adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review